Hubid, Mary Jane B.
HRN: 06-69-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2024
MUPIROCIN 2%, 15G (TUBE)
04/25/2024
05/02/2024
TOPICAL
Apply On Affected Area
BID
SP Repeat CS W IUD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes